echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Approval of pramipexole hydrochloride tablets of Shiyao group

    Approval of pramipexole hydrochloride tablets of Shiyao group

    • Last Update: 2020-01-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 2, 2020, Petrochemicals Group announced that the company's new four generic drug pramipexole hydrochloride tablets (enzie) were approved by the State Food and Drug Administration for listing, and the first one passed the consistency evaluation, mainly for the treatment of idiopathic Parkinson's disease Pramipexole hydrochloride tablets are mainly used to treat the signs and symptoms of idiopathic Parkinson's disease, that is to say, in the whole process of the disease, including the late stage of the disease, when the efficacy of levodopa is gradually weakened or changes and fluctuations (end of dose phenomenon or "on-off" fluctuation) occur, it can be used alone (without levodopa) or in combination with levodopa According to the pharmaceutical intelligence database, Zhejiang Jingxin Pharmaceutical Co., Ltd was approved in August 2018 as the first one to register six categories of Proctor hydrochloride tablets in China, in addition to the original one At present, it has submitted a supplementary application for consistency evaluation Pramipexole hydrochloride tablets of Shiyao group is the second one approved for listing in China, but the first one has passed the consistency evaluation! Mengmeng's article is the integrated content of yaozhi.com, and the copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.